Drug: TAXOL Injury: Malignant neoplasm progression Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125303344 | TAXOL | Malignant neoplasm progression | ACTAVIS | 0.00 | F | 0 | 20160708 | US |
| 127404371 | TAXOL | Malignant neoplasm progression | TEVA | 0.00 | F | 0 | 20160913 | US |
| 127440041 | TAXOL | Malignant neoplasm progression | MYLAN | 0.00 | 0 | 20160914 | US | |
| 127602881 | TAXOL | Malignant neoplasm progression | NOVARTIS | 71.28 YR | F | 0 | 20160919 | US |
| 127716941 | TAXOL | Malignant neoplasm progression | NOVARTIS | 71.58 YR | F | 0 | 20160922 | US |
| 1114039422 | TAXOL | Malignant neoplasm progression | ROCHE | 63.32 YR | F | 43 KG | 20160720 | CA |
Total Records: 6 Number of Pages: 1